StockData
Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd (RDY) stock

RDYNYSEPharmaceutical PreparationsFiscal year ends March 31
Financials through fiscal 2026, year ended Mar 31, 2026Score 7/30
$14.83−0.15 (-1.00%)

Close on Nov 19, 2026Market cap $12.38BP/E 27.2Yield 0.57%

Dr Reddys Laboratories free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

For fiscal 2026 it was ₹33.43B, up 76.6% from the year before. Over ten years it grew 1.4% a year on average. The highest annual figure on record is ₹47.55B in fiscal 2023.

Annual free cash flow

PeriodPeriod endValueChange
FY2026Mar 31, 2026₹33.43B+76.6%
FY2025Mar 31, 2025₹18.92B-34.8%
FY2024Mar 31, 2024₹29.03B-39.0%
FY2023Mar 31, 2023₹47.55B+253.6%
FY2022Mar 31, 2022₹13.45B-48.2%
FY2021Mar 31, 2021₹25.96B+3.9%
FY2020Mar 31, 2020₹25.00B+14.9%
FY2019Mar 31, 2019₹21.75B+148.9%
FY2018Mar 31, 2018₹8.74B-5.4%
FY2017Mar 31, 2017₹9.24B-68.4%
FY2016Mar 31, 2016₹29.23B–

More Dr Reddys Laboratories figures

See a number that looks wrong?